Literature DB >> 16176466

Which diabetic patients should receive podiatry care? An objective analysis.

M McGill1, L Molyneaux, D K Yue.   

Abstract

INTRODUCTION: Diabetes is the leading cause of lower limb amputation in Australia. However, due to limited resources, it is not feasible for everyone with diabetes to access podiatry care, and some objective guidelines of who should receive podiatry is required.
METHODS: A total of 250 patients with neuropathy (Biothesiometer; Biomedical Instruments, Newbury, Ohio, USA) ( > 30, age < 65)) but no active foot lesion, and 222 without neuropathy matched for age, type of diabetes, gender and duration, was followed prospectively for 2 years. Sensation was also tested using a 10 g Semmes Weinstein monofilament (Royal Prince Alfred Hospital Diabetes Centre). After the baseline examination, patients were contacted at 6 months and thereafter yearly to determine ulcer status. Incidence of foot ulceration across different risk categories was calculated using Kaplan-Meier survival curve. Log-rank test and Cox's proportional model were used to compare groups. The Number Needed to Treat (NNT) to prevent one ulcer per year was calculated using the standard formulae.
RESULTS: During the follow-up period, 34 new ulcers occurred in the neuropathy group and three ulcers in the control group (chi2 (1df) = 21.3; P < 0.0001), equating to an annual incidence of 6.3% and 0.5%, respectively. Fifty-four per cent of the ulcers were due to trauma from footwear. Further stratification of the neuropathy group showed annual incidence of ulceration to be 4% for those with abnormal biothesiometer reading, but who could still feel the monofilament, 10% for those who cannot feel the monofilament and 26% for those with previous ulceration or amputation. Predictors of ulceration were past history of ulceration/amputation (chi2 = 27.8; P < 0.0001) and the presence of neuropathy (chi2 = 4.7; P = 0.03). Assuming a 55% relative risk reduction in ulceration from podiatry care (mean of estimates from 10 reports), the NNT to prevent one foot ulcer per year was: no neuropathy (vibration perception threshold (VPT) < 30)), NNT = 367; neuropathy (VPT > 30) alone, NNT = 45; +cannot feel monofilament, NNT = 18; +previous ulcer/amputation, NNT = 7.
CONCLUSION: Provision of podiatry care to diabetic patients should not be only economically based, but should also be directed to those with reduced sensation, especially where there is a previous history of ulceration or amputation.

Entities:  

Mesh:

Year:  2005        PMID: 16176466     DOI: 10.1111/j.1445-5994.2005.00880.x

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  17 in total

1.  Preulcerous Risk Situation in Diabetic Foot Syndrome: Proposal for a Simple Ulcer Prevention Score.

Authors:  Stephan Kress; Helmut Anderten; Anja Borck; Guido Freckmann; Lutz Heinemann; Ulrike Holzmüller; Bernd Kulzer; Alexandra Portele; Oliver Schnell; Helga Varlemann; Claudia Zemmrich; Ralf Lobmann
Journal:  J Diabetes Sci Technol       Date:  2020-06-10

Review 2.  Screening for the high-risk foot of ulceration: tests of somatic and autonomic nerve function.

Authors:  Vasiliki Argiana; Ioanna Eleftheriadou; Nicholas Tentolouris
Journal:  Curr Diab Rep       Date:  2011-08       Impact factor: 4.810

3.  Chronic wounds in Australia: A systematic review of key epidemiological and clinical parameters.

Authors:  Laura McCosker; Ruth Tulleners; Qinglu Cheng; Stefan Rohmer; Tamzin Pacella; Nick Graves; Rosana Pacella
Journal:  Int Wound J       Date:  2018-09-26       Impact factor: 3.315

4.  External validation and optimisation of a model for predicting foot ulcers in patients with diabetes.

Authors:  M Monteiro-Soares; M Dinis-Ribeiro
Journal:  Diabetologia       Date:  2010-04-06       Impact factor: 10.122

Review 5.  Nociception at the diabetic foot, an uncharted territory.

Authors:  Ernst A Chantelau
Journal:  World J Diabetes       Date:  2015-04-15

6.  Screening patients at risk for diabetic foot ulceration: a comparison between measurement of vibration perception threshold and 10-g monofilament test.

Authors:  Jean-Louis Richard; Lise Reilhes; Stéphanie Buvry; Monique Goletto; Jean-Luc Faillie
Journal:  Int Wound J       Date:  2012-08-14       Impact factor: 3.315

7.  Diabetic foot ulcers: practical treatment recommendations.

Authors:  Michael Edmonds
Journal:  Drugs       Date:  2006       Impact factor: 9.546

8.  Patients' perspectives on foot complications in type 2 diabetes: a qualitative study.

Authors:  Lone Gale; Kavita Vedhara; Aidan Searle; Terry Kemple; Rona Campbell
Journal:  Br J Gen Pract       Date:  2008-08       Impact factor: 5.386

9.  Large-fiber dysfunction in diabetic peripheral neuropathy is predicted by cardiovascular risk factors.

Authors:  Jackie Elliott; Solomon Tesfaye; Nish Chaturvedi; Rajiv A Gandhi; Lynda K Stevens; Celia Emery; John H Fuller
Journal:  Diabetes Care       Date:  2009-07-08       Impact factor: 17.152

10.  Australian Diabetes Foot Network: practical guideline on the provision of footwear for people with diabetes.

Authors:  Shan M Bergin; Vanessa L Nube; Jan B Alford; Bernard P Allard; Joel M Gurr; Emma L Holland; Mark W Horsley; Maarten C Kamp; Peter A Lazzarini; Ashim K Sinha; Jason T Warnock; Paul R Wraight
Journal:  J Foot Ankle Res       Date:  2013-02-26       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.